Facebook Linkedin RSS Twitter Youtube
Home 2024

Clinical trial

AI Drug Discovery Company Healx Raises $47M, Cleared to Test Neurofibromatosis Drug
Artificial Intelligence

AI Drug Discovery Company Healx Raises $47M, Cleared to Test Neurofibromatosis Drug

Animal Models and Their Alternatives Share the Preclinical Habitat
Cancer

Animal Models and Their Alternatives Share the Preclinical Habitat

Vector Production Would Benefit from Purpose-Built Processing Technology
Artificial Intelligence

Vector Production Would Benefit from Purpose-Built Processing Technology

Parkinson’s Disease Inclusionopathy Cell Models Aid Study of Disease Pathology
Drug Discovery

Parkinson’s Disease Inclusionopathy Cell Models Aid Study of Disease Pathology

Lecanemab Approval for Early Alzheimer’s Disease Hits Roadblock in Europe
Drug Discovery

Lecanemab Approval for Early Alzheimer’s Disease Hits Roadblock in Europe

Alzheimer’s Therapies Could Target Aβ Production by Oligodendrocytes, Not Just Neurons
Drug Discovery

Alzheimer’s Therapies Could Target Aβ Production by Oligodendrocytes, Not Just Neurons

Why Next-Generation Laboratory and Manufacturing Solutions Are Needed Now to Realize the Potential of Cell and Gene Therapies
Bioprocessing

Why Next-Generation Laboratory and Manufacturing Solutions Are Needed Now to Realize the Potential of Cell and Gene Therapies

Inflammation in Macrophages Found as a Driving Force in Rare Genetic Conditions
News

Inflammation in Macrophages Found as a Driving Force in Rare Genetic Conditions

GLP1 and Harmine Therapy Reverses Diabetes in Mice by Regenerating Beta Cells
Insights

GLP1 and Harmine Therapy Reverses Diabetes in Mice by Regenerating Beta Cells

Biosimilar Manufacturer Focuses on Process Optimization
Bioprocessing

Biosimilar Manufacturer Focuses on Process Optimization

1234...271Page 3 of 271
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.